D-0043-2024 Class III Terminated

Recalled by Imprimis NJOF, LLC — Ledgewood, NJ

FDA drug recall D-0043-2024 was initiated by Imprimis NJOF, LLC on Sep 20, 2023 and is designated Class III. Reason for recall: Subpotent: Out of Specification result observed for Ketorolac assay levels, below the 90.0-110.0% of label claim. The recall status is terminated (terminated Jul 17, 2025). Affected quantity: 6,228 bags + 15,360 boxes.

Recall details

Product Type
Drugs
Report Date
Oct 25, 2023
Initiation Date
Sep 20, 2023
Termination Date
Jul 17, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
6,228 bags + 15,360 boxes

Product description

MYDRIATIC-4: Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution Drops 1% - 0.5% - 2.5% - 0.5%, 5mL bottle, Imprimis, NJOF, 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852 (844)-446-6979, NDC:71384-632-05

Reason for recall

Subpotent: Out of Specification result observed for Ketorolac assay levels, below the 90.0-110.0% of label claim.

Distribution pattern

Product was distributed to physician's offices nationwide.

Code information

Lot#s: 22DEC065 (MDU), exp: 09/29/2023; 23JAN024 (MDU), exp: 10/13/2023; 23FEB024 (SDU), exp: 11/09/2023; 23MAR013 (SDU), exp: 12/01/2023; 23MAR033 (SDU), exp: 12/16/2023; 23MAY044 (SDU), exp: 03/23/2024;

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0043-2024
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0043-2024. Report a data issue: hello@regdatalab.com.